Skip to main navigation Skip to search Skip to main content

Hepatitis C virus associated glomerulonephritis

Research output: Chapter in Book / Conference PaperChapter

Abstract

Approximately 170 million persons worldwide are infected with the hepatitis C (HCV) virus. The incidence of glomerulonephritis in HCV-infected patients is unknown due to a lack of large-scale cross sectional surveys however subclinical renal involvement is believed to be highly prevalent among patients with HCV hepatitis. The most common HCVassociated glomerulonephritis is membranoproliferative glomerulonephritis (MPGN) type 1 with or without cryoglobulinaemia. MPGN typically presents several years, and often decades, after initial infection with HCV. Most patients have laboratory evidence of hypocomplementaemia, circulating rheumatoid factors, and cryoglobulinaemia. Other uncommon forms of glomerular disease that have been reported to be associated with HCV infection include membranous nephropathy, IgA nephropathy, focal segmental glomerulosclerosis, fibrillary glomerulonephritis/immunotactoid glomerulopathy, pauciimmune glomerulonephritis, and thrombotic microangiopathy.
Original languageEnglish
Title of host publicationAn Update on Glomerulopathies: Clinical and Treatment Aspects
EditorsSharma Prabhakar
Place of PublicationCroatia
PublisherIntech Press
Pages169-188
ISBN (Print)9789533076737
Publication statusPublished - 2011

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Hepatitis C virus associated glomerulonephritis'. Together they form a unique fingerprint.

Cite this